基本信息
浏览量:3
职业迁徙
个人简介
I work to develop and evaluate better treatments for people with dementiaand for psychosis in older people by investigating the mechanisms ofsymptoms and through the conduct of independent clinical trials. For example, our trials have shown the cognitive, functional and independentliving benefits of continuing dementia drugs until the late stages of Alzheimer's disease (DOMINO) and of antipsychotic treatment in people with very late-onset schizophrenia-like psychosis (ATLAS). Currently, I am trialling the effectiveness of problem-adaptation therapy in people with dementia who are depressed (PATHFINDER).
I work with Suzanne Reeves to identify ways in which psychosis in olderpeople can be treated most effectively and safely through optimising the use ofexisting antipsychotics and investigating the potential of novel and repurposed agents (e.g. ondansetron in the TOP HAT trial). We're working with Emma McLachlan and Neil Burgess at theICN to understand how dysfunction of thehippocampus and associated structures might underpin confabulation and delusionformation in AD.
With Kathy Liu we are investigating the structure and function of central noradrenergic pathways whose dysfunction might underlie the common and hard-to-treat agitation syndrome seen in people with AD.
Anxiety disorders are the most difficult mental health problems to treat successfully in older people. With Becky Gould and colleagues, we are looking at Acceptance and Commitment Therapy for this and have just completed a feasibility trial in older people with treatment resistant generalised anxiety disorder (FACTOID trial).
I work with Suzanne Reeves to identify ways in which psychosis in olderpeople can be treated most effectively and safely through optimising the use ofexisting antipsychotics and investigating the potential of novel and repurposed agents (e.g. ondansetron in the TOP HAT trial). We're working with Emma McLachlan and Neil Burgess at theICN to understand how dysfunction of thehippocampus and associated structures might underpin confabulation and delusionformation in AD.
With Kathy Liu we are investigating the structure and function of central noradrenergic pathways whose dysfunction might underlie the common and hard-to-treat agitation syndrome seen in people with AD.
Anxiety disorders are the most difficult mental health problems to treat successfully in older people. With Becky Gould and colleagues, we are looking at Acceptance and Commitment Therapy for this and have just completed a feasibility trial in older people with treatment resistant generalised anxiety disorder (FACTOID trial).
研究兴趣
论文共 615 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Robert Howard, Elizabeth Cort,Charlotte Rawlinson, Martin Wiegand, Anne Downey, Vanessa Lawrence,Sube Banerjee, Peter Bentham,Chris Fox, Rowan Harwood, Rachel Hunter,Gill Livingston,
ALZHEIMERS & DEMENTIAno. 4 (2024): 2990-2999
Journal of Alzheimer's disease : JADno. 2 (2023): 473-482
引用0浏览0WOS引用
0
0
medRxiv : the preprint server for health sciences (2023)
引用0浏览0WOS引用
0
0
Jemma Hazan, Simon Hall, Alex Pemberton, Ian Sherriffs, Suzanne Joels,Amanda Heslegrave,Elena Veleva, Mamoona Ghauri,Rhiannon Laban,Emily Abel,Henrik Zetterberg,Nick C Fox,
JAMA Neurologyno. 5 (2023): 431-431
引用0浏览0引用
0
0
BRAIN COMMUNICATIONSno. 6 (2023): fcad322-fcad322
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn